PMID- 30178042
OWN - NLM
STAT- MEDLINE
DCOM- 20180926
LR  - 20181202
IS  - 1538-3598 (Electronic)
IS  - 0098-7484 (Linking)
VI  - 320
IP  - 10
DP  - 2018 Sep 11
TI  - Diagnosis and Treatment of Clostridium difficile Infection.
PG  - 1031-1032
LID - 10.1001/jama.2018.12194 [doi]
FAU - Gupta, Arjun
AU  - Gupta A
AD  - Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore,
      Maryland.
FAU - Cifu, Adam S
AU  - Cifu AS
AD  - Department of Internal Medicine, University of Chicago, Chicago, Illinois.
FAU - Khanna, Sahil
AU  - Khanna S
AD  - Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - JAMA
JT  - JAMA
JID - 7501160
RN  - 0 (Aminoglycosides)
RN  - 0 (Anti-Bacterial Agents)
RN  - 6Q205EH1VU (Vancomycin)
RN  - Z5N076G8YQ (Fidaxomicin)
SB  - AIM
SB  - IM
CIN - JAMA. 2019 Feb 5;321(5):512-513. PMID: 30721288
MH  - Adult
MH  - Aminoglycosides/therapeutic use
MH  - Anti-Bacterial Agents/*therapeutic use
MH  - Child
MH  - *Clostridium Infections/diagnosis/drug therapy/therapy
MH  - Clostridium difficile/genetics
MH  - *Fecal Microbiota Transplantation
MH  - Fidaxomicin
MH  - Humans
MH  - Nucleic Acid Amplification Techniques
MH  - *Practice Guidelines as Topic
MH  - Recurrence
MH  - Vancomycin/*therapeutic use
EDAT- 2018/09/05 06:00
MHDA- 2018/09/27 06:00
CRDT- 2018/09/05 06:00
PHST- 2018/09/05 06:00 [pubmed]
PHST- 2018/09/27 06:00 [medline]
PHST- 2018/09/05 06:00 [entrez]
AID - 2698674 [pii]
AID - 10.1001/jama.2018.12194 [doi]
PST - ppublish
SO  - JAMA. 2018 Sep 11;320(10):1031-1032. doi: 10.1001/jama.2018.12194.